Back
Southern Vs. Akero Therapeutics Industry Stock Comparison
Buy
73
SO
Southern
Last Price:
$90.41
Seasonality Move:
1.23%
Buy
51
AKRO
Akero Therapeutics
Last Price:
$55.05
Seasonality Move:
30.3%
Buy
51
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $53.92. The Score for AKRO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SO Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $53.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
SO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 57.81 | Buy |
Chaikin Money Flow: | 268138 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.56 - 90.22) | Buy |
Bollinger Bands (100): | (86.66 - 91.2) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.56 | Buy |
Relative Strength Index (14 RSI): | 61.7 | Buy |
Chaikin Money Flow: | -1344142 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.05 - 55.47) | Buy |
Bollinger Bands (100): | (40.1 - 52.22) | Buy |
SO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 89.7 | Buy |
20-day SMA: | 89.31 | Buy |
50-day SMA: | 89.79 | Buy |
200-day SMA: | 88.07 | Buy |
8-day EMA: | 89.78 | Buy |
20-day EMA: | 89.48 | Buy |
50-day EMA: | 89.37 | Buy |
200-day EMA: | 86.83 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.67 | Sell |
20-day SMA: | 52.61 | Buy |
50-day SMA: | 45.94 | Buy |
200-day SMA: | 37.63 | Buy |
8-day EMA: | 54.22 | Sell |
20-day EMA: | 52.25 | Buy |
50-day EMA: | 48.11 | Buy |
200-day EMA: | 39.5 | Buy |
Southern Earnings Growth & SO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.34 per share, an increase this year of $0.23 per share, and an increase next year of $0.29 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Southern Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |